passlisted in Coinbase#1 by calls of 844 on this host
0.005 USDC
per call, as the listing declares it on eip155:
- Validation state
- pass
- Uptime, 7 / 30 / 90 days
- 100% / 100% / 100%
- Calls, trailing 30 days
- 3
- Unique payers, trailing 30 days
- 1
- Last called
- 2026-09-28 14:05 UTC
- First observed by TOLLderived
- 2026-09-28
- Pricederived
- 0.005 USDC
- Networks
- 1
How big is this endpoint among the ones like it?
No trace is drawn of this endpoint’s own volume. Its counters have changed 2 times across 12 observations, and 3 changes are the fewest this site will draw a trace through, because two points and a guess are not a series. Every observation is in the JSON.
Of api.magentlab.com's 844 listings, calc irae hepatitis ranks tied 1st by calls with 5 others.
Callers of calc irae hepatitis supply a JSON body with the field items.
Its example response has the fields path, count and items.
calc irae hepatitis drew 3 calls from one payer in the trailing 30 days.
The last call to calc irae hepatitis came 4 days before the snapshot, 2026-09-28.
On Base, calc irae hepatitis asks 0.005 USDC per call.
calc irae hepatitis, a POST endpoint on api.magentlab.com, appears in the Coinbase registry; TOLL's taxonomy puts it in the "other" category.
calc irae hepatitis answered the sweep of 2026-10-01 with a valid 402, as at every sweep since 2026-09-28.
Closest in price to calc irae hepatitis within the "other" category: tech stack at agent402.tools and solana at agent.pocket.network.
calc irae hepatitis is priced above 43% of comparable listings in the "other" category.
calc irae hepatitis out-counts 83% of the 3,816 endpoints in the "other" category that carry counters.
The wallet paid by calc irae hepatitis is the payee of 844 endpoints on one host.
The seller's tags on calc irae hepatitis are irae-hepatitis, liver, checkpoint and asco.
735 other listings in the "other" category declare exactly the same price.
the payment options, as of 2026-10-02 05:34 UTC · method · pinnable
| registry | network | asset | amount | scheme | pay to |
|---|---|---|---|---|---|
| Coinbase | eip155: | USDC | 0.005 USDC | exact | 0x836Be2…c19Ee2 |
the checks, as of 2026-10-01 07:38 UTC · method · pinnableendpoint answered HTTP 402
No named check failed.
Every sweep that observed this endpoint, newest first.
| observed, UTC | state | failed checks | sweep |
|---|---|---|---|
| 2026-10-01 07:38 UTC | pass | 0 | daily-2026-10-01 |
| 2026-09-30 06:57 UTC | pass | 0 | daily-2026-09-30 |
| 2026-09-29 19:15 UTC | pass | 0 | daily-2026-09-29 |
| 2026-09-28 16:56 UTC | pass | 0 | daily-2026-09-28 |
| 2026-09-28 16:42 UTC | pass | 0 | new-after-daily-2026-09-28 |
Presence in a registry, not liveness of the service (method). Newest first.
- listed in Coinbase
From the registry record, not validated by TOLL.the declared schema, as of 2026-09-28 14:05 UTC · method · live
The input and output block
{
"input": {
"body": {
"items": [
{
"alt_u_l": 50,
"ast_u_l": 80,
"alt_uln_u_l": 40,
"ast_uln_u_l": 40,
"bilirubin_mg_dl": 1,
"bilirubin_uln_mg_dl": 1,
"decompensated_liver": false,
"symptomatic_liver_dysfunction": false
},
{
"alt_u_l": 50,
"ast_u_l": 80,
"alt_uln_u_l": 40,
"ast_uln_u_l": 40,
"bilirubin_mg_dl": 1,
"bilirubin_uln_mg_dl": 1,
"decompensated_liver": false,
"symptomatic_liver_dysfunction": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/irae_hepatitis",
"count": 2,
"items": [
{
"grade": 1,
"alt_u_l": 50,
"ast_u_l": 80,
"formula": "irae_hepatitis",
"citation": {
"id": "brahmer-2018",
"doi": "10.1200/JCO.2017.77.6385",
"pmid": "29442540",
"title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline",
"source": "J Clin Oncol. 2018;36(17):1714-1768",
"authors": "Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA"
},
"criteria": [
{
"met": false,
"factor": "decompensated_liver"
},
{
"met": false,
"factor": "symptomatic_liver_dysfunction"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"alt_uln_u_l": 40,
"ast_uln_u_l": 40,
"icpi_action": "continue",
"bilirubin_mg_dl": 1,
"bilirubin_ratio": 1,
"formula_expression": "lab_grade = max(transaminase_grade(max(AST/AST_ULN, ALT/ALT_ULN)), bilirubin_grade(TBili/TBili_ULN)); first-match: decompensated_liver -> max(lab_grade, 4); else symptomatic_liver_dysfunction -> max(lab_grade, 3); else lab_grade. Transaminase: <1x -> 0, ULN-3x -> 1, >3-5x -> 2, >5-20x -> 3, >20x -> 4. Bilirubin: <1x -> 0, ULN-1.5x -> 1, >1.5-3x -> 2, >3-10x -> 3, >10x -> 4 (Brahmer 2018 Table 2.2). icpi_action: 0-1 continue, 2 hold, 3-4 permanently_discontinue. mg/dL bilirubin only. Not DILI/RUCAM. Not R factor. magent does not assay enzymes. Not a diagnosis. Not a steroid dose",
"transaminase_ratio": 2,
"bilirubin_uln_mg_dl": 1,
"decompensated_liver": false,
"symptomatic_liver_dysfunction": false
},
{
"grade": 1,
"alt_u_l": 50,
"ast_u_l": 80,
"formula": "irae_hepatitis",
"citation": {
"id": "brahmer-2018",
"doi": "10.1200/JCO.2017.77.6385",
"pmid": "29442540",
"title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline",
"source": "J Clin Oncol. 2018;36(17):1714-1768",
"authors": "Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA"
},
"criteria": [
{
"met": false,
"factor": "decompensated_liver"
},
{
"met": false,
"factor": "symptomatic_liver_dysfunction"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"alt_uln_u_l": 40,
"ast_uln_u_l": 40,
"icpi_action": "continue",
"bilirubin_mg_dl": 1,
"bilirubin_ratio": 1,
"formula_expression": "lab_grade = max(transaminase_grade(max(AST/AST_ULN, ALT/ALT_ULN)), bilirubin_grade(TBili/TBili_ULN)); first-match: decompensated_liver -> max(lab_grade, 4); else symptomatic_liver_dysfunction -> max(lab_grade, 3); else lab_grade. Transaminase: <1x -> 0, ULN-3x -> 1, >3-5x -> 2, >5-20x -> 3, >20x -> 4. Bilirubin: <1x -> 0, ULN-1.5x -> 1, >1.5-3x -> 2, >3-10x -> 3, >10x -> 4 (Brahmer 2018 Table 2.2). icpi_action: 0-1 continue, 2 hold, 3-4 permanently_discontinue. mg/dL bilirubin only. Not DILI/RUCAM. Not R factor. magent does not assay enzymes. Not a diagnosis. Not a steroid dose",
"transaminase_ratio": 2,
"bilirubin_uln_mg_dl": 1,
"decompensated_liver": false,
"symptomatic_liver_dysfunction": false
}
]
}
}
}Cite this page
The pinned URL below renders this page from the snapshot of 2026-10-02 05:34 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).
Plain text
TOLL, "calc irae hepatitis on api.magentlab.com", snapshot of 2026-10-02 05:34 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-irae-hepatitis-59cb7d/at/2026-10-02T05-34Z. Accessed [access date].
BibTeX
@misc{toll-e-api-magentlab-com-api-calc-irae-hepatitis-59cb7d-2026-10-02T05-34Z,
author = {TOLL},
title = {calc irae hepatitis on api.magentlab.com},
howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-irae-hepatitis-59cb7d/at/2026-10-02T05-34Z}},
year = {2026},
month = {10},
note = {Pinned view of the snapshot of 2026-10-02 05:34 UTC. Accessed [access date].}
}None yet. Anything submitted through the form below is published here with its outcome.